Genbioma Aplicaciones S.L.
About
GENBIOMA offers a groundbreaking solution. We develop a personalised microbiome-based platform targeting type 2 diabetes (T2D), pre-diabetes (PreD), and gestational diabetes (GestD) through innovative probiotic and postbiotic formulations, harnessing the power of proprietary bacterial strains pA1c™ and pA2c™. Affordable probiotic and postbiotics that can revert blood sugar levels to normal with just one daily dose. Stable, safe, and natural nutritonal ingredientes and supplements complementary to diet and medication, with the potential to reduce T2D-associated healthcare expenses.
Our business strategy is to operate within a B2B framework spanning the pharma and food sectors.
Focus Areas